Philippa Roxby Health reporter Getty Images A new type of drug for one of the most common kinds of advanced breast cancer is now available on the NHS in England. Some 3,000 women a year could benefit from capivasertib after a clinical trial showed it can slow progression of the disease, and shrink tumours in...
